有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(Z)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-[(4-methylphenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C19H16BrFN4OS3 |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-N-[(2R)-2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]propyl]acetamide | —— | C19H26N6O2S2 |
|
—— | 2-[4-[(1S)-1-(4-methylsulfanylphenyl)ethyl]-1,4-diazepan-1-yl]ethanamine | —— | C16H27N3S |
|
—— | 3-[4-[(1S)-1-(4-methylsulfanylphenyl)ethyl]piperazin-1-yl]propan-1-amine | —— | C16H27N3S |
|
—— | (3S)-3-piperidin-4-yl-3-(4-propan-2-ylsulfanylphenyl)propan-1-ol | —— | C17H27NOS |
|
—— | (3R)-3-piperidin-4-yl-3-(4-propan-2-ylsulfanylphenyl)propan-1-ol | —— | C17H27NOS |
|
—— | 3-[2-(4-Ethylsulfanylphenyl)-1,3-thiazol-4-yl]propanoic acid | —— | C14H15NO2S2 |
|
—— | 2-[4-[(1R)-1-(4-methylsulfanylphenyl)ethyl]-1,4-diazepan-1-yl]ethanamine | —— | C16H27N3S |
|
—— | 3-[3-(4-ethylsulfanylphenyl)-1,2-thiazol-5-yl]propanoic acid | —— | C14H15NO2S2 |
|
—— | 4-[4-(4-methylsulfanylphenyl)-1,3-thiazol-2-yl]butanoic acid | —— | C14H15NO2S2 |
|
—— | 2-[4-[(1R)-1-(4-ethylsulfanylphenyl)ethyl]piperazin-1-yl]ethanamine | —— | C16H27N3S |
|
—— | 2-[4-[(1S)-1-(4-ethylsulfanylphenyl)ethyl]piperazin-1-yl]ethanamine | —— | C16H27N3S |
|
—— | [(Z)-[1-methyl-5-phenylsulfanyl-3-(trifluoromethyl)pyrazol-4-yl]methylideneamino] benzoate | —— | C19H14F3N3O2S |
|
—— | 1-[2-methyl-4-(4-methylsulfanylphenyl)butan-2-yl]-1,4-diazepane | —— | C17H28N2S |
|
—— | 4-[4-(4-ethylsulfanylphenyl)-1,3-thiazol-2-yl]butan-1-amine | —— | C15H20N2S2 |
|
—— | 6-(4-cyclopentylsulfanylphenyl)-2-methylhexan-2-ol | —— | C18H28OS |
|
—— | 1-[4-(4-ethylsulfanylphenyl)-2-methylbutan-2-yl]piperazine | —— | C17H28N2S |
|
—— | 3-[4-(4-propan-2-ylsulfanylphenyl)-1,3-thiazol-2-yl]propan-1-amine | —— | C15H20N2S2 |
|
—— | 1-piperazin-1-yl-3-(4-propan-2-ylsulfanylphenyl)propan-1-one | —— | C16H24N2OS |
|
—— | 3-[5-(4-propan-2-ylsulfanylphenyl)-1,3,4-oxadiazol-2-yl]propanoic acid | —— | C14H16N2O3S |
|
—— | 6-(4-cyclopentylsulfanylphenyl)-2-methylhexan-2-amine | —— | C18H29NS |
|
—— | 3-chloro-5-(4-cyclopentylsulfanylphenyl)-1,2,4-triazine | —— | C14H14ClN3S |
|
—— | [5-(4-cyclopentylsulfanylphenyl)-1,3,4-thiadiazol-2-yl]methanamine | —— | C14H17N3S2 |
|
—— | 2-[3-methyl-5-(4-propan-2-ylsulfanylphenyl)-1,2-oxazol-4-yl]acetic acid | —— | C15H17NO3S |
|
—— | 3-[5-(4-propan-2-ylsulfanylphenyl)-1,2-oxazol-3-yl]propanoic acid | —— | C15H17NO3S |
|
—— | 3-[5-(4-ethylsulfanylphenyl)-3-methyl-1,2-oxazol-4-yl]propanoic acid | —— | C15H17NO3S |
|
—— | N-[(Z)-[3-bromo-4-(dimethylamino)phenyl]methylideneamino]-2-pyrimidin-2-ylsulfanylacetamide | —— | C15H16BrN5OS |
|
—— | 2-(4-methylsulfanylphenyl)imidazo[2,1-b][1,3,4]thiadiazole-6-carboxylic acid | —— | C12H9N3O2S2 |
|
—— | (6E)-4-chloro-6-[[2-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfanyl]anilino]methylidene]cyclohexa-2,4-dien-1-one | —— | C18H16ClN3OS |
|
—— | (2R)-N-[(Z)-(4-bromophenyl)methylideneamino]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C16H17BrN4OS |
|
—— | 2-[2-(4-methylsulfanylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-6-yl]ethanamine | —— | C13H14N4S2 |
|
—— | [2-(4-cyclopentylsulfanylphenyl)-1,3-thiazol-4-yl]methanamine | —— | C15H18N2S2 |
|
—— | 2-(4-propan-2-ylsulfanylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-6-amine | —— | C13H14N4S2 |
|
—— | 2-[4-(1,4-diazepan-1-yl)phenyl]-5-methylsulfanyl-1,3,4-oxadiazole | —— | C14H18N4OS |
|
—— | (2R,4R)-2-(4-methylsulfanylphenyl)-4-piperidin-4-ylcyclopentan-1-one | —— | C17H23NOS |
|
—— | [4-(4-cyclopentylsulfanylphenyl)thiophen-3-yl]methanamine | —— | C16H19NS2 |
|
—— | 2-[3-(4-methylsulfanylphenyl)imidazo[5,1-b][1,3]thiazol-5-yl]ethanamine | —— | C14H15N3S2 |
|
—— | (2R,4S)-2-(4-methylsulfanylphenyl)-4-piperidin-4-ylcyclopentan-1-one | —— | C17H23NOS |
|
—— | (2S,4R)-2-(4-methylsulfanylphenyl)-4-piperidin-4-ylcyclopentan-1-one | —— | C17H23NOS |
|
—— | (2S,4S)-2-(4-methylsulfanylphenyl)-4-piperidin-4-ylcyclopentan-1-one | —— | C17H23NOS |
|
—— | 3-(4-propan-2-ylsulfanylphenyl)imidazo[5,1-b][1,3]thiazol-5-amine | —— | C14H15N3S2 |
|
—— | 2-[4-(4-ethylsulfanylphenyl)-6-methyl-1,3,5-triazin-2-yl]acetic acid | —— | C14H15N3O2S |
|
—— | 3-(4-propan-2-ylsulfanylphenyl)imidazo[2,1-b][1,3]thiazol-6-amine | —— | C14H15N3S2 |
|
—— | 2-[5-(4-cyclopentylsulfanylphenyl)-1,3,4-oxadiazol-2-yl]ethanamine | —— | C15H19N3OS |
|
—— | 5-(4-cyclopentylsulfanylphenyl)-1,2-oxazole-4-carboxylic acid | —— | C15H15NO3S |
|
—— | [5-(4-cyclopentylsulfanylphenyl)-3-methyl-1,2-oxazol-4-yl]methanamine | —— | C16H20N2OS |
|
—— | 2-[5-(4-cyclopentylsulfanylphenyl)-1,2-oxazol-3-yl]ethanamine | —— | C16H20N2OS |
|
—— | 5-(4-cyclopentylsulfanylphenyl)thiophene-2-carbaldehyde | —— | C16H16OS2 |
|
—— | 2-[4-methyl-6-(4-propan-2-ylsulfanylphenyl)-1,3,5-triazin-2-yl]ethanamine | —— | C15H20N4S |
|
—— | 2-[3-(4-propan-2-ylsulfanylphenyl)pyrazin-2-yl]acetic acid | —— | C15H16N2O2S |
|